188 related articles for article (PubMed ID: 11283129)
1. Esophageal cancer: the mode of lymphatic tumor cell spread and its prognostic significance.
Hosch SB; Stoecklein NH; Pichlmeier U; Rehders A; Scheunemann P; Niendorf A; Knoefel WT; Izbicki JR
J Clin Oncol; 2001 Apr; 19(7):1970-5. PubMed ID: 11283129
[TBL] [Abstract][Full Text] [Related]
2. Mode of spread in the early phase of lymphatic metastasis in non-small-cell lung cancer: significance of nodal micrometastasis.
Izbicki JR; Passlick B; Hosch SB; Kubuschock B; Schneider C; Busch C; Knoefel WT; Thetter O; Pantel K
J Thorac Cardiovasc Surg; 1996 Sep; 112(3):623-30. PubMed ID: 8800148
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of lymph node metastases of 217 cases of thoracic esophageal carcinoma and its impact on prognosis].
An FS; Huang JQ; Chen SH
Ai Zheng; 2003 Sep; 22(9):974-7. PubMed ID: 12969532
[TBL] [Abstract][Full Text] [Related]
4. Analysis of micrometastatic disease in histologically negative lymph nodes of patients with adenocarcinoma of the distal esophagus or gastric cardia.
Buskens CJ; Ten Kate FJ; Obertop H; Izbicki JR; van Lanschot JJ
Dis Esophagus; 2008; 21(6):488-95. PubMed ID: 18840133
[TBL] [Abstract][Full Text] [Related]
5. [Lymphatic metastasis intensity of and lymphadenectomy for thoracic esophageal squamous cell carcinoma].
Lu ZM; Zhang H; Wang MH; Cui DH; Yang YQ; Huang HZ
Ai Zheng; 2006 May; 25(5):604-8. PubMed ID: 16687083
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small-cell lung cancer.
Passlick B; Izbicki JR; Kubuschok B; Nathrath W; Thetter O; Pichlmeier U; Schweiberer L; Riethmüller G; Pantel K
J Clin Oncol; 1994 Sep; 12(9):1827-32. PubMed ID: 8083707
[TBL] [Abstract][Full Text] [Related]
7. Significance of immunohistochemically demonstrated micrometastases to lymph nodes in esophageal cancer with histologically negative nodes.
Komukai S; Nishimaki T; Watanabe H; Ajioka Y; Suzuki T; Hatakeyama K
Surgery; 2000 Jan; 127(1):40-6. PubMed ID: 10660757
[TBL] [Abstract][Full Text] [Related]
8. Prognostic relevance of skip metastases in esophageal cancer.
Prenzel KL; Bollschweiler E; Schröder W; Mönig SP; Drebber U; Vallboehmer D; Hölscher AH
Ann Thorac Surg; 2010 Nov; 90(5):1662-7. PubMed ID: 20971285
[TBL] [Abstract][Full Text] [Related]
9. The prognostic importance of immunohistochemically detected node metastases in resected esophageal adenocarcinoma.
Waterman TA; Hagen JA; Peters JH; DeMeester SR; Taylor CR; Demeester TR
Ann Thorac Surg; 2004 Oct; 78(4):1161-9; discussion 1161-9. PubMed ID: 15464464
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of the survival in patients after surgical resection of thoracic esophageal cancer].
Zhang HL; Liu RL; Shi YT; Wang ZC; Wang BH; Li YJ; Zhou LY; Ping YM
Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):541-5. PubMed ID: 19950705
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of perigastric lymph nodes metastases on survival in patients with thoracic esophageal cancer.
Wu ZY; Yu JC; Xu LY; Shen JH; Wu JZ; Wang SH; Fu JH; Fan YH; Yang BN; Shen ZY; Huang Q; Li EM
Dis Esophagus; 2010 Jan; 23(1):40-5. PubMed ID: 19392853
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer.
Izbicki JR; Hosch SB; Pichlmeier U; Rehders A; Busch C; Niendorf A; Passlick B; Broelsch CE; Pantel K
N Engl J Med; 1997 Oct; 337(17):1188-94. PubMed ID: 9337377
[TBL] [Abstract][Full Text] [Related]
13. Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer.
Kaifi JT; Yekebas EF; Schurr P; Obonyo D; Wachowiak R; Busch P; Heinecke A; Pantel K; Izbicki JR
J Natl Cancer Inst; 2005 Dec; 97(24):1840-7. PubMed ID: 16368946
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with gallbladder carcinoma.
Sasaki E; Nagino M; Ebata T; Oda K; Arai T; Nishio H; Nimura Y
Ann Surg; 2006 Jul; 244(1):99-105. PubMed ID: 16794394
[TBL] [Abstract][Full Text] [Related]
15. Prognostic evaluation and review of immunohistochemically detected disseminated tumor cells in peritumoral lymph nodes of patients with pN0 colorectal cancer.
Rosenberg R; Friederichs J; Gertler R; Hoos A; Mueller J; Nahrig J; Nekarda H; Siewert JR
Int J Colorectal Dis; 2004 Sep; 19(5):430-7. PubMed ID: 14716495
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of micrometastases in esophageal and colorectal carcinoma (a clinical experience).
Laso CA; González JJ; Fresno F; Azcano E; Sanz L; Navarrete F
Hepatogastroenterology; 2004; 51(58):964-7. PubMed ID: 15239225
[TBL] [Abstract][Full Text] [Related]
17. [Value of 2-field lymphadenectomy in intrathoracic esophageal carcinoma].
Meyer HJ; Jähne J; Hiller WF; Tusch G; Stukenborg C; Pichlmayr R
Zentralbl Chir; 1996; 121(2):106-9. PubMed ID: 8868604
[TBL] [Abstract][Full Text] [Related]
18. Lymph node micrometastasis and prognosis in patients with oesophageal squamous cell carcinoma.
Sato F; Shimada Y; Li Z; Watanabe G; Maeda M; Imamura M
Br J Surg; 2001 Mar; 88(3):426-32. PubMed ID: 11260111
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of nodal micrometastases in patients with cancer of the gastro-oesophageal junction.
Heeren PA; Kelder W; Blondeel I; van Westreenen HL; Hollema H; Plukker JT
Eur J Surg Oncol; 2005 Apr; 31(3):270-6. PubMed ID: 15780562
[TBL] [Abstract][Full Text] [Related]
20. Total number of resected lymph nodes predicts survival in esophageal cancer.
Altorki NK; Zhou XK; Stiles B; Port JL; Paul S; Lee PC; Mazumdar M
Ann Surg; 2008 Aug; 248(2):221-6. PubMed ID: 18650631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
